InsiderTrades

Form 4 for ALKS Alkermes plc.

Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-08 · accession 0001520262-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-01-08 2026-01-08 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx $19.34 +5,000 66.7K +8% +$96.7K
D 2026-01-08 2026-01-08 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off S - Sale+OE $30.00 -5,000 61.7K -7% -$150.0K
D 2026-01-08 2026-01-08 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx $0.00 -5,000 31.4K -14% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2026-01-08 M A 5,000 $19.34 66,740 D — —
2 Common Ordinary Shares 2026-01-08 S D 5,000 $30.00 61,740 D — — (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
3 Derivative Employee Stock Option (Right to Buy) 2026-01-08 M D 5,000 $0.00 31,356 D $19.34 · — to 2031-02-22 5,000 Ordinary Shares (F4) These options are fully vested in accordance with their terms.